With a high energy density, lithium–sulfur batteries (LSB) are regarded as one of the promising next‐generation energy storage systems. However, many challenges hinder the practical applications of LSB, such as the dendrite formations/parasitic reactions on the Li metal anode and the “shuttle effect” of lithium polysulfides of the LSB cathode. Herein, a novel diluted medium‐concentrated electrolyte (DMCE) is developed by adding 1,1,2,2‐tetrafluoroethyl 2,2,3,3‐tetrafluoropropyl ether (TTE) into a dual salt medium‐concentrated electrolyte (MCE) consisting of lithium bis(trifluoromethanesulfonyl)imide (LiTFSI)–lithium bis(fluorosulfonyl)imide (LiFSI)/tetrahydrofuran (THF)–dipropyl ether (DPE). The optimized DMCE electrolyte is capable of protecting the Li metal anode and suppresses the dissolution of polysulfides and the “shuttle effect”, delivering a high coulombic efficiency (CE) of Li plating–stripping up to 99.6% even at a low concentration of Li salt (1.0–2.0 m). Impressively, compared with the cells cycled in the MCE electrolyte, the LiS cells with the DMCE‐2.0 m electrolyte have delivered an enhanced initial capacity of 682 mAh g−1 with an excellent capacity retention of 92% for 500 cycles. This strategy of using fluorinated ether as diluent solvent in a medium‐concentrated electrolyte can accelerate the commercialization of LSB.
Orthohantaviruses can cause two types of human infections: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). HFRS is a zoonotic disease transmitted by multiple rodent species. Yunnan Province in southwest China is the natural foci of HFRS, and Dali Prefecture in Yunnan Province has the highest incidence of HFRS; however, the precise status of orthohantavirus infection in Dali Prefecture remains unknown. To this end, we obtained clinical data of HFRS patients from the medical records of the People's Hospital of Xiangyun County in Dali Prefecture from July 2019 to August 2021. We collected epidemiological data of HFRS patients through interviews and investigated host animals using the night clip or night cage method. We systematically performed epidemiological analyses of patients and host animals. The differences in the presence of rodent activity at home (2=8.75, P=0.031<0.05), of rodent-proof equipment in the food (2=9.19, P=0.025<0.05), and of rodents or rodent excrement in the workplace (2=10.35, P=0.014<0.05) were statistically different in the four clinical types, including mild, medium, severe, and critical HFRS-associated diseases. Furthermore, we conducted molecular detection of orthohantavirus in host animals. The total orthohantavirus infection rate of rodents was 2.7% (9/331); the specific infection rate of specific animal species was 6.1% (5/82) for the Apodemus chevrieri, 100% (1/1) for the Rattus nitidus, 3.8% (2/53) for the Rattus norvegicus, and 12.5% (1/8) for the Crocidura dracula. In this study, a total of 21 strains of orthohantavirus were detected in patients and rodents. The 12 orthohantavirus strains from patients showed a closer relationship with Seoul orthohantavirus (SEOOV) L0199, DLR2, and GZRn60 strains; the six orthohantavirus strains from Rattus norvegicus and Apodemus chevrieri were closely related to SEOOV GZRn60 strain; One strains (XYRn163) from Rattus norvegicus and one strain (XYR.nitidus97) from Rattus nitidus were closely related to SEOOV DLR2 strain; the orthohantavirus strain from Crocidura dracula was closely related to the Luxi orthohantavirus (LUXV) LX309 strain. In conclusion, patients with HFRS in Xuangyun County of Dali Prefecture are predominantly affected by SEOOV, with multiple genotypes of orthohantavirus in host animals, and most importantly, these orthohantavirus strains constantly demonstrated zoonotic risk in humans.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.